Company VioQuest Pharmaceuticals, Inc. Other OTC
Equities
VOQP
US9276252023
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Asymmetric Products and Technology
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 09-02-08 | |
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,461,644 | 5,461,644 ( 100.00 %) | 0 | 100.00 % |
Company contact information
VioQuest Pharmaceuticals, Inc.
PO Box 2287
55402, Minneapolis
+
Sector
1st Jan change | Capi. | |
---|---|---|
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |